Delmitide

N/A

Report date: 2022/03/14 18:05:41
NME

Base Information

Drug NameDelmitide
Drug Alias Name迪米肽DelmitidaDelmitidum地米肽Rationally Designed Peptide 58 +[8] 
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionImmunosuppressantsTumor necrosis factor β inhibitorsInterferon gamma inhibitors +[4] 
TargetsTumor necrosis factor βInterferon gammaInterleukin-12
Therapy Area/IndicationsCrohn DiseaseColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGenzyme Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenzyme CorpProcter & Gamble Company
Active IndicationsN/A
Inactive IndicationsCrohn DiseaseColitis, Ulcerative

Other Information

ATC CodeN/A
Related LinksKEGG